Intravenous Immunoglobulin Treatment in Neurologic Disorders
Arch Neurol 56:1025-1027,1032, Sorensen,P.S., 1999
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke
Stroke 51:e124-e127, Valdes Valderrama, E.,et al, 2020
Combined Corticosteroid and Antiviral Treatment for Bell Palsy: A Systematic Review and Meta-analysis
JAMA 302:985-993, 1003, Almeida,J.,et al, 2009
Potassium Channel Antibody-Associated Encephalopathy: A Potentially Immunotherapy-Responsive Form of Limbic Encepahlitis
Brain 127:701-712, Vincent,A.,et al, 2004
Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003
Smallpox, Bioterrorism, and the Neurologist
Arch Neurol 60:489-494, Cleri,D.J.,et al, 2003
Intraspinal Steroids: History, Efficacy, Accidentality, and Controversy with Review of United States Food and Drug Administration Reports
JNNP 70:433-443, Nelson,D.A. & Landau,W.M., 2001
Effect of Early Interferon Treatment on Conversion to Definite Multiple Sclerosis: A Randomised Study
Lancet 357:1576-1582,1547, Comi,G.,et al, 2001
Therapeutic Dilemma
Neurol 54:1404-1407, Romanelli,F.,et al, 2000
Multiple Sclerosis--From Probable to Definite Diagnosis
Arch Neurol 57:974-979,930, Achiron,A. & Barak,Y., 2000
Glucocorticoids in Central Nervous System Bacterial Infection
Arch Neurol 56:796-801, Coyle,P.K., 1999
Population Based Cost Utility Study of Interferon Beta-1b in Secondary Progressive Multiple Sclerosis
BMJ 319:1529-1533, Forbes,R.B.,et al, 1999
Interferons in the Treatment of Multiple Sclerosis,Do They Prevent the Progression of the Disease?
Arch Neurol 55:1578-1580,1583, Rice,G.&Ebers,G, 1998
Interferons Should be Used to Treat Most Patients with MS
Arch Neurol 55:1581-1583, Herndon,R.M.&Jacobs,L, 1998
Yes, Brain Biopsy Should be a Prerequisite for Herpes Simplex Encephalitis Treatment
Arch Neurol 44:1289-1292, Hanley,D.F.,et al, 1987
Primary Diffuse Leptomeningeal Melanocytosis, A Diagnoatic Conundrum
Neurol 101:e576-3580, Selvarajan,J.M.P.,et al, 2023
Diagnosis of Multiple Sclerosis: Progress and Challenges
Lancet 389:1336-1346, Brownlee, W.J.,et al, 2017
Hydrocephalus in Children
Lancet 387:788-799, Kahle, K.T.,et al, 2016
Infective Endocarditis
Lancet 387:882-893, Cahill, T.J. & Prendergast, B.D., 2016
Neuromyelitis Optica: Evaluation of 871 Attacks and 1,153 Treatment Courses
Ann Neurol 79:206-216,204, Kleiter, I.,et al, 2016
Should Doctors Prescribe Cannabinoids?
BMJ 348:g2737, Farrell, M.,et al, 2014
Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012
Adjunctive Dexamethasone in Adults with Meningococcal Meningitis
Neurol 79:1563-1569,1528, Heckenberg, S.G.B.,et al, 2012
Preventive Antibiotics in Acute Stroke
Stroke 43:e113-e114, Westendrop, W.F.,et al, 2012
Immune Reconstitution Inflammatory Syndrome in Natalizumab-Associated PML
Neurol 77:1061-1067,1033, Tan, I.L.,et al, 2011
Hereditary Hemorrhagic Telangiectasia (Osler-Weber-Rendu Syndrome)
UpToDate, Feb, Shovlin, C., 2011
PANDAS
www.medlink.com,Feb, Erfe,M.C.B., 2011
Open Biopsy in Patients With Acute Progressive Neurologic Decline and Absence of Mass Lesion
Neurol 75:419-424, Schuette,A.J., et al, 2010
How Beneficial is Surgery for Cervical Radiculopathy and Myelopathy?
BMJ 341:200-202, Fouyas,I.P., et al, 2010
Generic Anticonvulsant Use in Children: Do We Have Evidence to Recommend Brand Formulations?
Arch Neurol 66:1417-1418, Hamiwka,L., 2009
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
Corticosteroids and Mortality in Children With Bacterial Meningitis
JAMA 299:2048-2055, Mongelluzzo,J.,et al, 2008
Corticosteroids for Acute Bacterial Meningitis
NEJM 357:2507-2509, Greenwood,B.M., 2007
Homocysteine and Stroke: Evidence on a Causal Link From Mendelian Randomisation
Lancet 365:224-232, 194, Casas, J.P., et al, 2005
Thrombosis of the Cerebral VEins and Sinuses
NEJM 352:1791-1798, Stam,J., 2005
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Stiff-Person Syndrome
The Neurologist 10:131-137, Murinson,B.B., 2004
The Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection (PANDAS) Etiology for Tics and Obsessive-Compulsive Symptoms: Hypothesis or Entity? Practical Considerations for the Clinician
Pediatrics 113:883-886, Kurlan,R. &Kaplan,E., 2004
Dexamethasone in Adults with Bacterial Meningitis
NEJM 347:1549-1556,1613, de Gans,J.,et al, 2002
Prognosis for Seizure Recurrence in Patients with Newly Diagnosed Neurocysticercosis
Neurol 59:1730-1734,1669, Carpio,A. &Hauser,W.A., 2002
Increased Plasma Methylmalonic Acid Level Does Not Predict Clinical Manifestations of Vitamin B12 Deficiency
Arch Int Med 161:1534-1541, Hvas,A.,et al, 2001
Computed Tomography of the Head Before Lumbar Puncture in Adults With Suspected Meningitis
NEJM 345:1727-1733,1768, Hasbun,R.,et al, 2001
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Is the Course of Neurocysticercosis Modified by Treatment with Anthelmintic Agents
Arch Int Med 157:128-129, DelBrutto,O.H., 1997
The Therapeutic Dilemma of Inclusion Body Myositis
Neurol 48:567-568, Barohn,R.J., 1997
Medical Treatment of Cysticercosis-Ineffective
Arch Neurol 52:101-102, 1041995., Kramer,L.D., 1995
Medical Treatment of Cysticercosis-Effective
Arch Neurol 52:102-104, DelBrutto,O.H., 1995
Is the Course of Neurocysticercosis Modified by Treatment with Antihelminthic Agents
Arch Int Med 155:1982-1988, Carpio,A.,et al, 1995
A Plasma Exchange Versus Immune Globulin Infusion Trial in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Ann Neurol 36:838-845, Dyck,P.J.,et al, 1994